Pharmaceutical Packaging Market Size & Share 2026-2035

Pharmaceutical Packaging Market Size

The global pharmaceutical packaging market was valued at USD 172.6 billion in 2025. The market is expected to grow from USD 198 billion in 2026 to USD 405.1 billion in 2031 & USD 744.6 billion in 2035, at a CAGR of 15.9% during the forecast period according to the latest report published by Global Market Insights Inc.

The rise in global pharmaceutical demand is a major growth drive in the market. The increasing aging population and increasing prevalence of chronic diseases is pushing the expansion of pharmaceutical industries which demand durable and high-quality packaging. This growth is driving the adoption of diverse packaging solutions, including glass, rigid plastics, blister packs, pouches, and compostable materials, which ensure product stability, extend shelf life, and maintain drug efficacy. According to a Statista report, global pharmaceutical industry accounted for USD 1.6 trillion dollars in the year 2023. In addition, the rise in the use of generic injectable drugs, which depend on specialized glass packaging solutions such as vials and ampoules, is also adding to the growth of the market.

The pharmaceutical glass manufacturers need to develop vials and ampoules that are durable and chemically resistant to meet the growing demand from the pharma industry. Innovation in lightweight, break-resistant, and eco-friendly glass packaging will improve drug safety, regulatory standards, and competitiveness in the market.

Another significant growth drive in pharmaceutical packaging market is the stringent packaging regulations for drug safety. Various regulatory bodies such as FDA (U.S. Food and Drug Administration), EMA (European Medicines Agency), and WHO (World Health Organization) enforces strict packaging guidelines to ensure drug stability and contamination prevention for injectable drugs and vaccines. This regulatory need is propelling the transition from conventional glass to Type 1 borosilicate glass packaging because of its enhanced chemical resistance and extreme temperature resistance benefits.

Additionally, the surge in biopharmaceuticals, vaccines, and injectable drugs is creating demand for specialized packaging solutions that meet high sterility standards. Packaging manufacturers are investing in automated filling, sterilization-compliant systems, and multi-layer barrier technologies to protect sensitive formulations. The preference for ready-to-use packaging across hospitals, pharmacies, and clinics further accelerates market adoption.

Pharmaceutical Packaging Market Trends

• One of the major trends in the market is the integration of RFID, NFC tags, and track-and-trace systems to improve drug security, supply chain efficiency, and anti-counterfeiting measures. Manufacturers are increasingly using tamper-evident seals, serialization, and unique identification codes across glass, plastic, and blister packaging formats.
• Adoption of advanced high-quality glass and rigid packaging materials remains a prominent trend. Type 1 borosilicate glass and chemically inert rigid plastics are being increasingly used to maintain drug stability, sterility, and shelf-life across injectables, oral liquids, and sensitive formulations.
• Break-resistant, delamination-free, and multi-layer barrier coatings are gaining traction across glass, plastic, and blister packaging. These innovations prevent material breakage, minimize chemical interactions, reduce leaching risks, and ensure safe drug delivery, enhancing patient safety and regulatory compliance.
• There is a growing emphasis on eco-friendly and sustainable packaging solutions, including biodegradable films, compostable pouches, and recyclable rigid containers. Pharmaceutical manufacturers are adopting these solutions to reduce environmental impact while meeting global sustainability regulations.
• Prefilled and ready-to-use packaging formats, such as prefilled syringes, cartridges, unit-dose blister packs, and multi-dose vials, are increasingly preferred by healthcare providers to simplify drug administration, reduce contamination risk, and optimize operational efficiency.

Pharmaceutical Packaging Market Analysis

Based on packaging type, the market is divided into primary packaging, secondary packaging, and tertiary packaging.

• The primary packaging segment led the market in 2025, holding a 70.4% share. The growth of this segment is driven by the rising demand for injectables, vaccines, biologics, and oral liquid drugs, which require safe, sterile, and chemically stable packaging that comes in direct contact with the drug. Primary packaging solutions such as vials, ampoules, prefilled syringes, blister packs, and bottles ensure drug integrity, patient safety, and compliance with stringent regulatory standards. Increasing adoption of ready-to-use packaging and advanced barrier technologies further support the dominance of this segment.
• The secondary packaging segment is expected to grow at a CAGR of 17.1% over the forecast period. The rising focus on product branding, serialization, and tamper-evident packaging for regulatory compliance and anti-counterfeiting measures is driving demand. Secondary packaging solutions, including cartons, folding boxes, blister backings, and pouches, facilitate product protection, supply chain efficiency, and marketing appeal, making it the fastest-growing segment in the market.

Based on packaging format, the pharmaceutical packaging market is divided into rigid packaging, semi-rigid packaging, and flexible packaging.

• The rigid packaging segment led the market in 2025, holding a 56.5% share. Growth in this segment is driven by the rising demand for injectables, tablets, capsules, and liquid formulations, which require chemically stable, durable, and tamper-evident containers. Rigid packaging solutions, including glass vials, bottles, cartridges, and rigid plastic containers, ensure drug safety, extend shelf life, and comply with stringent regulatory standards. Increasing adoption of prefilled and ready-to-use rigid formats further strengthens the dominance of this segment.
• The flexible packaging segment is expected to grow at a CAGR of 17.8% over the forecast period. The rising focus on lightweight, cost-effective, and sustainable packaging solutions is driving this segment’s growth. Flexible packaging formats, such as pouches, sachets, foil wraps, and unit-dose films, offer convenience, reduced material usage, extended shelf life, and enhanced portability, making them the fastest-growing segment in the market.

Based on end-user, the pharmaceutical packaging market is divided into pharmaceutical manufacturers, contract manufacturing organizations (CMOs), hospitals & healthcare facilities, and retail pharmacies.

• The pharmaceutical manufacturers segment led the market in 2025, holding a 46.1% share. Growth in this segment is driven by the increasing production of generic drugs, biologics, vaccines, and injectable therapies, which require high-quality, safe, and regulatory-compliant packaging solutions. Manufacturers rely on primary packaging such as vials, bottles, ampoules, prefilled syringes, and blister packs to ensure drug stability, sterility, and patient safety, making them the largest end-user segment in the market.
• The contract manufacturing organizations (CMOs) segment is expected to grow at a CAGR of 16.8% over the forecast period, making it the fastest-growing segment. The rising trend of outsourcing pharmaceutical production and packaging to CMOs for cost efficiency, scalability, and compliance is driving this growth. CMOs increasingly adopt ready-to-use primary packaging, flexible and rigid formats, and serialized secondary packaging, enabling manufacturers to meet regulatory requirements and optimize supply chain efficiency.

North America Pharmaceutical Packaging Market

North America pharmaceutical packaging industry held a share of 35.3% of market in 2025.

• The region is witnessing a strong shift towards high-quality, sustainable, and regulatory-compliant packaging solutions. Pharmaceutical companies are increasingly adopting advanced glass, rigid plastics, and flexible packaging with barrier coatings, prefilled systems, and tamper-evident features to ensure drug stability, sterility, and patient safety.
• Rising production of injectables, biologics, vaccines, and specialty drugs is a key driver for packaging demand. Government initiatives supporting sustainable packaging materials and serialization standards are further propelling adoption of high-performance containers across all primary and secondary formats.

The U.S. pharmaceutical packaging market was valued at USD 34.9 billion and USD 40.1 billion in 2022 and 2023, respectively. The market size reached USD 53.1 billion in 2025, growing from USD 46.1 billion in 2024.

• The U.S. market is growing at a steady rate due to rising demand for injectable drugs, biologics, and vaccines, along with increasing production of generic and specialty pharmaceuticals. The expansion of domestic drug manufacturing and growing prefillable syringes and sterile vials are further supporting market growth.
• The country has developed pharmaceutical industry, and the increasing production and export of biologics and vaccines are the key growth drivers in the region. For instance, according to Statista, the U.S. was the largest pharmaceutical industry in the year 2023, generating more than USD 670 million in revenue. In addition, the rapid expansion of contract development and manufacturing organizations (CDMOs) further supports the growth of market in the region.

Europe Pharmaceutical Packaging Market

Europe market accounted for USD 47.6 billion in 2025 and is anticipated to show lucrative growth over the forecast period.

• In Europe, the market is expanding due to strict regulatory compliance, EU GMP standards, and circular economy initiatives encouraging sustainable and recyclable packaging. Countries like Germany, France, and the U.K. are investing in advanced manufacturing lines and high-purity glass solutions for biologics and sterile injectables.
• The region is seeing strong adoption of prefilled syringes, ampoules, and rigid containers for sterile drug delivery. Harmonized safety regulations, smart packaging initiatives, and sustainability-focused policies are driving innovation, operational efficiency, and long-term growth across the pharmaceutical sector.

Germany dominates the Europe market, showcasing strong growth potential.

• Germany is a key market for pharmaceutical packaging in Europe, driven by its strong pharmaceutical manufacturing base and strict quality standards. EU GMP-aligned regulations and sustainability policies are promoting the adoption of high-purity, recyclable glass and advanced packaging solutions. Robust production of biologics, vaccines, and injectable drugs is further boosting demand for vials, ampoules, bottles, and prefillable devices.
• The country’s well-established pharmaceutical industry, combined with stringent government packaging requirements, ensures steady demand for high-performance packaging. In addition, approvals for biologic drug production are accelerating the adoption of prefilled syringes, cartridges, and ready-to-use packaging systems, supporting operational efficiency and compliance.

Asia Pacific Pharmaceutical Packaging Market

The Asia Pacific market is expected to grow to the highest CAGR of 16.8% during the forecast period.

• In Asia-Pacific, the market is growing rapidly due to increased production of biologics, biosimilars, and generic drugs. Countries such as China, India, and Japan are adopting high-performance glass, rigid, and flexible packaging for safe drug storage and distribution.
• The region is witnessing strong adoption of prefilled syringes, vials, and barrier-coated containers supported by government programs for centralized drug procurement, vaccination campaigns, and improved regulatory compliance. Rising healthcare access, urbanization, and disposable income are further driving long-term market expansion.

China market is estimated to grow with a significant CAGR, in the Asia Pacific market.

• China is a major market for pharmaceutical packaging in Asia-Pacific, driven by its large domestic pharmaceutical manufacturing base and strong presence of vaccine and injectable drug producers. Rising production of biologics, biosimilars, and generic injectables is fueling demand for high-quality vials, bottles, and prefillable systems.
• Government initiatives, including centralized drug procurement programs and alignment with international quality standards, are encouraging adoption of premium borosilicate glass and advanced packaging solutions. Strengthened GMP compliance requirements are further driving manufacturers toward durable, chemically resistant, and dimensionally precise packaging for safe and effective drug delivery.

Middle East and Africa Pharmaceutical Packaging Market

• The Middle East and Africa market is witnessing steady growth, driven by increasing investments in domestic pharmaceutical manufacturing, biologics production, and vaccine distribution. Countries such as UAE, Saudi Arabia, and South Africa are adopting high-quality glass, rigid, and flexible packaging for safe drug storage and distribution.
• Government initiatives promoting drug safety, regulatory compliance, and sustainable packaging practices are accelerating adoption of prefilled syringes, vials, bottles, and barrier-coated packaging solutions. Growing healthcare infrastructure, urbanization, and expansion of contract manufacturing organizations (CMOs) are further supporting market growth across the region.
   

Pharmaceutical Packaging Market Share

The market is highly competitive and moderately fragmented, with the presence of established global players, regional manufacturers, and emerging innovators. The top players in the market, including Amcor plc, Gerresheimer AG, West Pharmaceutical Services, Inc., AptarGroup, Inc., and Schott AG, collectively account for a 10.2% share of the global market. These companies leverage diversified portfolios across rigid, flexible, and drug delivery packaging solutions, supported by strong global manufacturing networks and advanced R&D capabilities.

Major players are increasingly investing in sustainable materials, advanced barrier technologies, and patient-centric packaging solutions to meet stringent regulatory requirements and evolving pharmaceutical needs. The market is witnessing rapid innovation in prefilled syringes, flexible packaging formats, recyclable materials, and high-performance glass and plastic containers, ensuring drug safety, stability, and extended shelf life. Additionally, the rising prevalence of chronic diseases such as diabetes, cardiovascular conditions, and cancer is driving demand for injectables, biologics, and oral medications, thereby increasing the need for reliable, high-quality pharmaceutical packaging solutions across global markets.

Pharmaceutical Packaging Market Companies

Prominent players operating in the market are as mentioned below:

• Alpla Group
• Amcor plc
• AptarGroup, Inc.
• Becton, Dickinson and Company (BD)
• Bormioli Pharma
• CCL Industries Inc.
• Comar LLC
• Datwyler Holding Inc.
• Gerresheimer AG
• Huhtamaki Oyj
• Nipro Corporation
• Origin Pharma Packaging
• Schott AG
• SCHOTT Kaisha Private Limited
• SGD Pharma
• Stevanato Group S.p.A.
• West Pharmaceutical Services, Inc.

• Amcor plc

Amcor plc provides a comprehensive portfolio of rigid and flexible pharmaceutical packaging solutions, including bottles, blister packs, sachets, and closures. The company emphasizes sustainability, recyclable materials, and advanced barrier technologies to enhance drug protection, shelf life, and patient convenience across global markets.

• Gerresheimer AG

Gerresheimer AG offers a wide range of glass and plastic pharmaceutical packaging solutions, including vials, ampoules, cartridges, and prefillable syringes. The company focuses on high-precision manufacturing, regulatory compliance, and sustainable production practices to support pharmaceutical and biotech industries worldwide.

• West Pharmaceutical Services, Inc.

West Pharmaceutical Services specializes in injectable drug packaging and delivery systems, including stoppers, seals, and prefilled syringe components. The company emphasizes high-performance materials, containment solutions, and regulatory expertise to ensure drug safety and integrity, particularly for biologics and parenteral drugs.

• AptarGroup, Inc.

AptarGroup, Inc., develops drug delivery and dispensing systems, including inhalers, nasal sprays, and ophthalmic solutions. The company focuses on patient-centric design, precision dosing technologies, and innovative packaging components that improve drug administration, adherence, and therapeutic outcomes.

• Schott AG

Schott AG manufactures high-quality pharmaceutical glass packaging, including borosilicate glass vials, ampoules, and cartridges. The company leverages advanced material science and global production capabilities to deliver chemically stable, durable, and regulatory-compliant packaging solutions for sensitive drugs and biologics.

Pharmaceutical Packaging Industry News

• In February 2026, Gerresheimer showcased its sustainable glass packaging solutions for food, natural cosmetics, and nutraceuticals at BIOFACH 2026 in Nuremberg. The company highlighted lightweight, refillable, and high post-consumer recycled glass designs, emphasizing reduced carbon footprint, product safety, and premium aesthetics. This initiative reinforces Gerresheimer’s commitment to sustainability, supporting clients in achieving circular economic goals while expanding adoption of eco-friendly glass packaging across global markets.
• In October 2025, Amcor showcased its latest patient-centric and sustainable pharmaceutical packaging innovations at CPHI Frankfurt 2025. The company highlighted ClariPPil jars, easy-squeeze ophthalmic bottles, RS01X connected inhalers, AmSky thermoform blister systems, and High Shield Pharma Laminates. The solutions focused on improving drug stability, user convenience, adherence, and environmental sustainability, while demonstrating advanced barrier protection, prefilled formats, and digital connectivity to support healthcare providers and patients globally.
• In August 2025, SCHOTT launched local production of high-precision syringe and cartridge glass tubing at its Jambusar, Gujarat facility, becoming the first in India to do so. This expansion, leveraging German technology, aimed to meet growing demand for GLP-1-based injectables like semaglutide, enhance India’s pharmaceutical self-reliance under the “Make in India” initiative, and strengthen the supply of borosilicate FIOLAX tubing for prefillable syringes, cartridges, vials, and ampoules across India and Asia.

The pharmaceutical packaging market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue (USD Billion) from 2022 – 2035 for the following segments:

Click here to Buy Section of this Report

Market, By Packaging Type

• Primary packaging
  • Blister packs
  • Bottles & containers
  • Vials & ampoules
  • Prefilled syringes & cartridges
  • Pouches & sachets
  • Others
• Secondary packaging
  • Cartons & boxes
  • Labels & leaflets
  • Trays
• Tertiary packaging
  • Pallets
  • Corrugated boxes
  • Stretch wrap & shrink film

Market, By Packaging Format

• Rigid packaging
• Semi-rigid packaging
• Flexible packaging

Market, By Material Type

• Plastics
  • HDPE
  • PET
  • PP
  • PE
  • Others
• Glass
• Aluminum
• Paper & paperboard
• Others

Market, By Functionality

• Conventional packaging
• Sterile packaging
• Child-resistant & tamper-evident packaging
• Serialization-enabled packaging
• Temperature-controlled packaging (Cold-Chain)

Market, By Drug Form

• Solid dosage
• Liquid/injectable
• Biologics & biosimilars
• Dermal & topical
• Ophthalmic
• Pulmonary/inhalation
• Others

Market, By End User

• Pharmaceutical manufacturers
• Contract manufacturing
• Hospitals & healthcare facilities
• Retail pharmacies

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea

• Latin America
  • Brazil
  • Mexico
  • Argentina

• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE